Home » Analyst sells all stocks in personal portfolio on Anthropic IPO day

On the day Anthropic brought a record $81.3 billion stock offering to Nasdaq, Panmure Liberum analyst Joachim Klement said he’s selling every stock in his personal portfolio.

The Claude maker priced its IPO at $83 a share, above the top of its initial range, and the Nasdaq Composite rose 2% in early trading Thursday.

But Klement is watching a different number.

The benchmark S&P 500 had slipped below its 200-day moving average (MA) – triggering a “rule” that calls for him to shift his money into long-term government bonds.

Why Klement is pulling out of the stock market

Klement told CNBC he would sell his US and overseas stocks at the end of European trading on Nov. 19.

His rule uses the SPX’s average closing level over the past 200 trading sessions to gauge whether the broader market is losing momentum.

If the index moves back above that line, he plans to buy stocks again.

Klement did acknowledge that the breach could prove a possible “false trigger.”

He noted that the index crossed its 200-day average more than 10 times around each of the previous bubble peaks his team examined before losses accelerated.

That history helps explain why his rule has a way back into stocks, even if it means trading repeatedly through a choppy market.

Klement’s view on Anthropic IPO

“The Anthropic IPO doesn’t change my mind,” Klement told The Wall Street Journal.

His team is watching what the biggest cloud providers will spend next year.

Klement pointed to Microsoft scaling back deals with specialist cloud providers and putting more emphasis on data centers it builds itself.

He sees room for 2027 spending guidance to come in below expectations, which could leave chip suppliers with fewer orders than investors have priced in.

Anthropic’s economics are a second test. Panmure Liberum read the IPO filings as showing that revenue growth was slowing while compute costs were becoming harder to outrun.

The offering showed how much capital investors would commit.

The filings gave them a way to judge how efficiently Anthropic turns that spending into sales.

Where Klement sees shelter inside the stock market

For investors who want to keep owning equities, Panmure Liberum looked at which European stocks held up around the 10 worst sessions this year for Goldman Sachs’ Broad AI Basket.

Its UK standouts included GSK, AstraZeneca, Unilever and Reckitt Benckiser, giving investors several names to examine if they want less exposure to the AI spending cycle.

The comparison covers a handful of selloffs, so it offers limited evidence about how those shares would fare in a prolonged downturn.

Klement’s own next move is easier to pin down.

A recovery above the 200-day average would bring him back into stocks even if his concerns about AI spending persist.

AI disclosure: AI tools assisted with research and drafting of this piece. An Invezz editor reviewed the facts, sources and wording before publication. Any opinions or analysis are Invezz’s, not those of an automated system.

The post Analyst sells all stocks in personal portfolio on Anthropic IPO day appeared first on Invezz